Skip to search formSkip to main contentSkip to account menu

Cardiac total anomalous pulmonary venous connection

Known as: Type 2 total anomalous pulmonary venous connection 
Type 2 total anomalous pulmonary venous connection. [DDD:dbrown]
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Determining how the heliospheric magnetic field and plasma connect to the Sun’s corona and photosphere is, perhaps, the central… 
2012
2012
4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is a highly potent inhibitor of HIV-1 reverse transcriptase (RT). We have previously… 
Highly Cited
2008
Highly Cited
2008
We previously proposed that mutations in the connection subdomain (cn) of HIV-1 reverse transcriptase increase AZT resistance by… 
Highly Cited
2007
Highly Cited
2007
The aim of this study was to estimate the costs and the health benefits of the following interventions: increasing access to… 
2006
2006
Amongst the commonly employed transmission pricing philosophies in the decentralized markets, i.e., point-to-point and point-of… 
Highly Cited
2004
Highly Cited
2004
Background—Impaired cardiac autonomic nervous activities and increased neurohumoral activities (CANA, NHA) characterize Fontan… 
Highly Cited
1996
Highly Cited
1991
Highly Cited
1991
Arrhythmia was compared between 40 consecutive patients (pts) undergoing atriopulmonary connection (APC) and 40 undergoing total…